These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8827077)

  • 41. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.
    O'Keefe D; Dao D; Zhao L; Sanderson R; Warburton D; Weiss L; Anyane-Yeboa K; Tycko B
    Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
    Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
    J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma.
    el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V
    Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imprinting, expression, and localisation of DLK1 in Wilms tumours.
    Fukuzawa R; Heathcott RW; Morison IM; Reeve AE
    J Clin Pathol; 2005 Feb; 58(2):145-50. PubMed ID: 15677533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
    Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
    J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis.
    Okamoto K; Morison IM; Taniguchi T; Reeve AE
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5367-71. PubMed ID: 9144243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple genetic abnormalities of 11p15 in Wilms' tumor.
    Feinberg AP
    Med Pediatr Oncol; 1996 Nov; 27(5):484-9. PubMed ID: 8827078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
    Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
    Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased expression of p57(KIP2)mRNA in human bladder cancer.
    Oya M; Schulz WA
    Br J Cancer; 2000 Sep; 83(5):626-31. PubMed ID: 10944603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.
    Taniguchi T; Sullivan MJ; Ogawa O; Reeve AE
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2159-63. PubMed ID: 7534414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.
    Tessema M; Länger F; Bock O; Seltsam A; Metzig K; Hasemeier B; Kreipe H; Lehmann U
    Int J Oncol; 2005 Feb; 26(2):499-507. PubMed ID: 15645136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel imprinted gene, KCNQ1DN, within the WT2 critical region of human chromosome 11p15.5 and its reduced expression in Wilms' tumors.
    Xin Z; Soejima H; Higashimoto K; Yatsuki H; Zhu X; Satoh Y; Masaki Z; Kaneko Y; Jinno Y; Fukuzawa R; Hata Ji; Mukai T
    J Biochem; 2000 Nov; 128(5):847-53. PubMed ID: 11056398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletions and rearrangements of the H19/IGF2 enhancer region in patients with Silver-Russell syndrome and growth retardation.
    Grønskov K; Poole RL; Hahnemann JM; Thomson J; Tümer Z; Brøndum-Nielsen K; Murphy R; Ravn K; Melchior L; Dedic A; Dolmer B; Temple IK; Boonen SE; Mackay DJ
    J Med Genet; 2011 May; 48(5):308-11. PubMed ID: 21278389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor.
    Frevel MA; Sowerby SJ; Petersen GB; Reeve AE
    J Biol Chem; 1999 Oct; 274(41):29331-40. PubMed ID: 10506193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
    Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
    Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour.
    Cerrato F; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Rinaldi MM; Boccuto L; Neri G; Magnani C; D'Angelo P; Collini P; Perotti D; Sebastio G; Maher ER; Riccio A
    Hum Mol Genet; 2008 May; 17(10):1427-35. PubMed ID: 18245780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Mummert SK; Lobanenkov VA; Feinberg AP
    Genes Chromosomes Cancer; 2005 Jun; 43(2):155-61. PubMed ID: 15761865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
    Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
    Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression.
    Dejeux E; Olaso R; Dousset B; Audebourg A; Gut IG; Terris B; Tost J
    Endocr Relat Cancer; 2009 Sep; 16(3):939-52. PubMed ID: 19502451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour.
    Sparago A; Russo S; Cerrato F; Ferraiuolo S; Castorina P; Selicorni A; Schwienbacher C; Negrini M; Ferrero GB; Silengo MC; Anichini C; Larizza L; Riccio A
    Hum Mol Genet; 2007 Feb; 16(3):254-64. PubMed ID: 17158821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.